The Journal.The Wall Street Journal & Spotify Studios
Novo Nordisk CEO Mike Doustdar talks about launching a pill version of their blockbuster obesity drug Wegovy in the US. He speaks to Katie Greifeld in San Francisco at the annual JPMorgan Healthcare Conference.
See omnystudio.com/listener for privacy information.